Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes.
Stenberg ErikDhanisha Jayesh TrivediJohan OttossonSuzanne HedbergErik NäslundPublished in: Diabetes, obesity & metabolism (2024)
Semaglutide and MBS were both associated with improvements in weight and improved glycaemic control at 2 years after the start of the intervention, but MBS was associated with better weight loss and glucometabolic control.
Keyphrases
- weight loss
- type diabetes
- bariatric surgery
- glycemic control
- roux en y gastric bypass
- body mass index
- minimally invasive
- randomized controlled trial
- weight gain
- physical activity
- gastric bypass
- cardiovascular disease
- coronary artery bypass
- body weight
- obese patients
- skeletal muscle
- percutaneous coronary intervention